{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:23:22Z","timestamp":1747200202885,"version":"3.40.5"},"reference-count":19,"publisher":"Media Sphere Publishing House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. Ann. Ophthal."],"published-print":{"date-parts":[[2023,6,28]]},"abstract":"<jats:p>The article presents a clinical case of bilateral uveitis with macular edema that developed during long-term administration of vemurafenib. Methods of conservative treatment of malignant tumors are presently available and reasonably effective. However, at the same time drugs can have toxic effect on normal cells in various tissues of the body. According to our data, the use of corticosteroids can ameliorate the clinical signs of macular edema associated with uveitis, but with a tendency to recur. Only complete cancellation of vemurafenib provided remission of sufficient duration, which is fully consistent with clinical observations made by colleagues. Therefore, when prescribing long-term therapy with vemurafenib, in addition to periodic observation by an oncologist, it is also mandatory to continue follow-up observation by an ophthalmologist. Partnership between health care specialists could help avoid severe ocular complications.<\/jats:p>","DOI":"10.17116\/oftalma202313903169","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T16:07:37Z","timestamp":1687968457000},"page":"69","source":"Crossref","is-referenced-by-count":1,"title":["Bilateral uveitis associated with protein kinase inhibitor-based treatment of skin melanoma (case study)"],"prefix":"10.17116","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-1811","authenticated-orcid":false,"given":"E.V.","family":"Udovichenko","sequence":"first","affiliation":[{"name":"Khabarovsk branch of S.N. Fedorov Eye National Medical Research Center \u201cMNTK \u201cEye Microsurgery\u201d","place":["Khabarovsk, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-1755","authenticated-orcid":false,"given":"L.P.","family":"Danilova","sequence":"additional","affiliation":[{"name":"Khabarovsk branch of S.N. Fedorov Eye National Medical Research Center \u201cMNTK \u201cEye Microsurgery\u201d","place":["Khabarovsk, Russia"]},{"name":"Postgraduate Institute for Public Health Specialists","place":["Khabarovsk, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-1140","authenticated-orcid":false,"given":"E.L.","family":"Sorokin","sequence":"additional","affiliation":[{"name":"Khabarovsk branch of S.N. Fedorov Eye National Medical Research Center \u201cMNTK \u201cEye Microsurgery\u201d","place":["Khabarovsk, Russia"]},{"name":"Far-Eastern State Medical University","place":["Khabarovsk, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-3647","authenticated-orcid":false,"given":"A.A.","family":"Fil","sequence":"additional","affiliation":[{"name":"Khabarovsk branch of S.N. Fedorov Eye National Medical Research Center \u201cMNTK \u201cEye Microsurgery\u201d","place":["Khabarovsk, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma202313903169-1","doi-asserted-by":"publisher","DOI":"10.33978\/2307-3586-2020-16-33-46-50"},{"key":"key-10.17116\/oftalma202313903169-2","unstructured":"Vladimirova LYu. Usage of MEK inhibitors in oncology: results and perspectives. Advances in Current Natural Sciences = Uspekhi sovremennogo yestestvoznaniya. 2015;(3):18-30. (In Russ.)"},{"key":"key-10.17116\/oftalma202313903169-3","unstructured":"Protsenko SA, Novik AV, Akhaeva ZY, Zhabina AS, Imyanitov EN, Semenova AI. Modern options in personalized therapy of metastatic cutaneous melanoma. Journal of Modern Oncology = Sovremennaya onkologiya. 2014;16(3):57-64. (In Russ.)"},{"key":"key-10.17116\/oftalma202313903169-4","unstructured":"Orlova KV, Kharkevich GYu, Demidov LV. Treatment of cancer with BRAF V600 gene mutation using vemurafenib. Farmateka. 2015;(18):57-60. (In Russ.)"},{"key":"key-10.17116\/oftalma202313903169-5","unstructured":"Kolbin AS, Kurylev AA, Balykina YuE, Proskurin MA. Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation. Good Clinical Practice = Kachestvennaya klinicheskaya praktika. 2017;(1):11-19. (In Russ.)"},{"key":"key-10.17116\/oftalma202313903169-6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002451"},{"key":"key-10.17116\/oftalma202313903169-7","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000242"},{"key":"key-10.17116\/oftalma202313903169-8","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000585"},{"key":"key-10.17116\/oftalma202313903169-9","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920944359"},{"key":"key-10.17116\/oftalma202313903169-10","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2018-0002"},{"key":"key-10.17116\/oftalma202313903169-11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102892"},{"key":"key-10.17116\/oftalma202313903169-12","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02635-3"},{"key":"key-10.17116\/oftalma202313903169-13","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120930688"},{"key":"key-10.17116\/oftalma202313903169-14","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1695860"},{"key":"key-10.17116\/oftalma202313903169-15","unstructured":"Moshirfar M, Villarreal A, Ronquillo Y. Tyrosine kinase inhibitor keratitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021"},{"key":"key-10.17116\/oftalma202313903169-16","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma202113701194"},{"key":"key-10.17116\/oftalma202313903169-17","doi-asserted-by":"publisher","DOI":"10.21516\/2072-0076-2020-13-3-88-91"},{"key":"key-10.17116\/oftalma202313903169-18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.07.003"},{"key":"key-10.17116\/oftalma202313903169-19","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-015-0049-9"}],"container-title":["Russian Annals of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:47:46Z","timestamp":1745502466000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/vestnik-oftalmologii\/2023\/3\/10042465X2023031069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6,28]]}},"alternative-id":["10.17116\/oftalma202313903169"],"URL":"https:\/\/doi.org\/10.17116\/oftalma202313903169","relation":{},"ISSN":["0042-465X"],"issn-type":[{"type":"print","value":"0042-465X"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}